We recently found a gene signature for multiple sclerosis (MS) that reverted to normal during pregnancy in MS patients and included NR4A2 and TNFAIP3, key molecules in anti-inflammatory processes. Here we focus on the expression levels of these two genes in monocytes and CD4+ T cells from healthy controls and treatment-naïve RRMS patients. Our findings show that monocytes play a key role in the dysregulated anti-inflammatory response, being the expression of both genes down-regulated in these cells in RRMS patients with respect to healthy individuals. CD4 + T cells seem to have only a marginal part, because we can observe only a slight down-regulation in NR4A2.
Introduction
In a previous study we showed that gene expression of seven genes was normalized during pregnancy (Gilli et al., 2010) . In the present work we focused on two out of seven genes, namely nuclear receptor subfamily 4, group A, member 2 (NR4A2) and tumor necrosis factor, α-induced protein 3 (TNFAIP3), because they play a key role in the negative regulation of inflammation (Wertz et al., 2004; Saijo et al., 2009) , and have been already involved in the pathogenesis of several autoimmune and neurodegenerative disorders (Plenge et al., 2007; Musone et al., 2008; Dieudé et al., 2010; Ma and Malynn, 2013) . Furthermore, recently other groups have demonstrated their association with multiple sclerosis (Achiron et al., 2004 (Achiron et al., , 2010 Mandel et al., 2004; Satoh et al., 2005; International Multiple Sclerosis Genetics Consortium, 2013) .
NR4A2 belongs to the NR4A subfamily of orphan nuclear receptors. NR4As are early response genes whose expression is induced by various stimuli including cyclic AMP, growth factors, inflammatory signals, and hormones (Maxwell and Muscat, 2006) . In recent years the role of NR4A2 in MS has been investigated, obtaining conflicting results. On one hand, it has been demonstrated that NR4A2 is involved in controlling the transcription of NF-κB target genes (Saijo et al., 2009) , and in the development of Treg cells (Sekiya et al., 2011 (Sekiya et al., , 2013 ; its low expression has been correlated with MS (Achiron et al., 2004 (Achiron et al., , 2010 Mandel et al., 2004) . On the other hand, it has been shown to have a role in the differentiation of Th17 cells (Raveney et al., 2013) and to be overexpressed in a population of Japanese MS patients (Satoh et al., 2005) .
TNFAIP3 plays a key role in the restriction of NF-κB signaling (Wertz et al., 2004) , and is also involved in the promotion of cell-survival signals (Lee et al., 2000) . Single nucleotide polymorphisms (SNPs) in the TNFAIP3 gene have been linked with susceptibility to different human autoimmune diseases, such as rheumatoid arthritis (Plenge et al., 2007) , systemic lupus erythematosus (Musone et al., 2008) , systemic sclerosis (Dieudé et al., 2010) , and only recently to MS (International Multiple Sclerosis Genetics Consortium, 2013). Besides our abovementioned work (Gilli et al., 2010) , the down-regulation of TNFAIP3 expression in MS patients has been highlighted by Mandel and colleagues (Mandel et al., 2004) .
To investigate the function of these two genes, we aimed at identifying particular cell subpopulations having a pivotal role in the unbalanced expression of NR4A2 and TNFAIP3. To this purpose, we performed real-time PCR experiments on monocytes and CD4 + T cells obtained from a new cohort of healthy controls and MS patients of Caucasian origin.
Different studies have highlighted an important role of monocytes in MS pathogenesis. In fact, circulating monocytes from MS patients are present in active brain lesions, and upon stimulation during acute disease relapses, they express more pro-inflammatory cytokines (Bustamante et al., 2013) . 
